| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (Cortex KO) / (Cortex WT) | Abundance Ratio (log2): (Cortex KO) / (Cortex WT) | Abundance Ratio P-Value: (Cortex KO) / (Cortex WT) | Abundance Ratio Adj. P-Value: (Cortex KO) / (Cortex WT) | Abundance Ratio Variability [%]: (Cortex KO) / (Cortex WT) | Abundances (Grouped): Cortex KO | Abundances (Grouped): Cortex WT | Abundances (Grouped) CV [%]: Cortex KO | Abundances (Grouped) CV [%]: Cortex WT | Abundances (Scaled): F1: 129, Sample, Cortex KO, 1 | Abundances (Scaled): F1: 130, Sample, Cortex KO, 2 | Abundances (Scaled): F1: 131, Sample, Cortex KO, 3 | Abundances (Scaled): F1: 126, Sample, Cortex WT, 1 | Abundances (Scaled): F1: 127, Sample, Cortex WT, 2 | Abundances (Scaled): F1: 128, Sample, Cortex WT, 3 | Abundances (Normalized): F1: 129, Sample, Cortex KO, 1 | Abundances (Normalized): F1: 130, Sample, Cortex KO, 2 | Abundances (Normalized): F1: 131, Sample, Cortex KO, 3 | Abundances (Normalized): F1: 126, Sample, Cortex WT, 1 | Abundances (Normalized): F1: 127, Sample, Cortex WT, 2 | Abundances (Normalized): F1: 128, Sample, Cortex WT, 3 | Abundance: F1: 129, Sample, Cortex KO, 1 | Abundance: F1: 130, Sample, Cortex KO, 2 | Abundance: F1: 131, Sample, Cortex KO, 3 | Abundance: F1: 126, Sample, Cortex WT, 1 | Abundance: F1: 127, Sample, Cortex WT, 2 | Abundance: F1: 128, Sample, Cortex WT, 3 | Abundances Count: F1: 129, Sample, Cortex KO, 1 | Abundances Count: F1: 130, Sample, Cortex KO, 2 | Abundances Count: F1: 131, Sample, Cortex KO, 3 | Abundances Count: F1: 126, Sample, Cortex WT, 1 | Abundances Count: F1: 127, Sample, Cortex WT, 2 | Abundances Count: F1: 128, Sample, Cortex WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | Q9QZF2 | Glypican-1 OS=Mus musculus OX=10090 GN=Gpc1 PE=1 SV=1 | 0 | 73.975 | 31 | 13 | 20 | 13 | 557 | 61.3 | 7.05 | 0.979 | -0.03 | 0.81280953 | 0.989960807 | 5.83 | 100.6 | 99.4 | 18.32 | 16.73 | 106.6 | 114.3 | 79.4 | 113.2 | 105.4 | 81.1 | 1435.4 | 1539.8 | 1069.5 | 1524.1 | 1419.3 | 1092.6 | 1346 | 1389.8 | 1067.9 | 1364.4 | 1235.1 | 1092.6 | 11 | 11 | 11 | 11 | 11 | 11 | cell differentiation;metabolic process;regulation of biological process | cytosol;endosome;extracellular;membrane;organelle lumen | metal ion binding;protein binding | Pf01153 | 14733 | Gpc1 | 1 | HS-GAG degradation; A tetrasaccharide linker sequence is required for GAG synthesis; Cell surface interactions at the vascular wall; Signaling by GPCR; Retinoid metabolism and transport; HS-GAG biosynthesis; Signaling by ROBO receptors | ENSMUSG00000034220.7 | Proteoglycans in cancer | 0 |